Cargando…

Deficits in neuronal architecture but not over-inhibition are main determinants of reduced neuronal network activity in a mouse model of overexpression of Dyrk1A

Abnormal dendritic arbors, dendritic spine “dysgenesis” and excitation inhibition imbalance are main traits assumed to underlie impaired cognition and behavioral adaptation in intellectual disability. However, how these modifications actually contribute to functional properties of neuronal networks,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manubens-Gil, Linus, Pons-Espinal, Meritxell, Gener, Thomas, Ballesteros-Yañez, Inmaculada, de Lagrán, María Martínez, Dierssen, Mara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028951/ https://www.ncbi.nlm.nih.gov/pubmed/36945607 http://dx.doi.org/10.1101/2023.03.09.531874

Ejemplares similares

Hippocampal changes produced by overexpression of the human CHRNA5/A3/B4 gene cluster may underlie cognitive deficits rescued by nicotine in transgenic mice
por: Molas, Susanna, et al.
Publicado: (2014)

Dyrk1A Is Dynamically Expressed on Subsets of Motor Neurons and in the Neuromuscular Junction: Possible Role in Down Syndrome
por: Arque, Gloria, et al.
Publicado: (2013)

DYRK1A (Dual-Specificity Tyrosine-Phosphorylated and -Regulated Kinase 1A): A Gene with Dosage Effect During Development and Neurogenesis
por: Dierssen, M., et al.
Publicado: (2006)

Fluorescent transgenic mouse models for whole-brain imaging in health and disease
por: Arias, Adrian, et al.
Publicado: (2022)

Impaired Spatial Learning Strategies and Novel Object Recognition in Mice Haploinsufficient for the Dual Specificity Tyrosine-Regulated Kinase-1A (Dyrk1A)
por: Arqué, Glòria, et al.
Publicado: (2008)

NGF Upregulates the Plasminogen Activation Inhibitor-1 in Neurons via the Calcineurin/NFAT Pathway and the Down Syndrome-Related Proteins DYRK1A and RCAN1 Attenuate This Effect
por: Stefos, Georgios C., et al.
Publicado: (2013)

DYRK1A Overexpression Alters Cognition and Neural-Related Proteomic Pathways in the Hippocampus That Are Rescued by Green Tea Extract and/or Environmental Enrichment
por: De Toma, Ilario, et al.
Publicado: (2019)

Lamivudine, a reverse transcriptase inhibitor, rescues cognitive deficits in a mouse model of down syndrome
por: Martinez de Lagran, Maria, et al.
Publicado: (2022)

Molecular Rescue of Dyrk1A Overexpression Alterations in Mice with Fontup(®) Dietary Supplement: Role of Green Tea Catechins
por: Gu, Yuchen, et al.
Publicado: (2020)

Proteomic profiling reveals mitochondrial dysfunction in the cerebellum of transgenic mice overexpressing DYRK1A, a Down syndrome candidate gene
por: Ortega, Mireia, et al.
Publicado: (2022)

Dissecting the non-neuronal cell contribution to Parkinson’s disease pathogenesis using induced pluripotent stem cells
por: Pons-Espinal, Meritxell, et al.
Publicado: (2020)

Neuronal Connectivity as a Determinant of Cell Types and Subtypes
por: Liu, Lijuan, et al.
Publicado: (2023)

Neuronal overexpression of Alzheimer's disease and Down's syndrome associated DYRK1A/minibrain gene alters motor decline, neurodegeneration and synaptic plasticity in Drosophila
por: Lowe, Simon A., et al.
Publicado: (2019)

Dyrk1a gene dosage in glutamatergic neurons has key effects in cognitive deficits observed in mouse models of MRD7 and Down syndrome
por: Brault, Véronique, et al.
Publicado: (2021)

Dyrk1a Phosphorylation of α-Synuclein Mediating Apoptosis of Dopaminergic Neurons in Parkinson's Disease
por: Yong, Yuxuan, et al.
Publicado: (2023)

Where Environment Meets Cognition: A Focus on Two Developmental Intellectual Disability Disorders
por: De Toma, I., et al.
Publicado: (2016)

DYRK1A antagonists rescue degeneration and behavioural deficits of in vivo models based on amyloid-β, Tau and DYRK1A neurotoxicity
por: Zhu, Bangfu, et al.
Publicado: (2022)

Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions
por: Dierssen, Mara, et al.
Publicado: (2020)

Increased dosage of DYRK1A and DSCR1 delays neuronal differentiation in neocortical progenitor cells
por: Kurabayashi, Nobuhiro, et al.
Publicado: (2013)

Sequential phosphorylation of NDEL1 by the DYRK2-GSK3β complex is critical for neuronal morphogenesis
por: Woo, Youngsik, et al.
Publicado: (2019)

Dyrk1A overexpression leads to increase of 3R-tau expression and cognitive deficits in Ts65Dn Down syndrome mice
por: Yin, Xiaomin, et al.
Publicado: (2017)

Synergic Functions of miRNAs Determine Neuronal Fate of Adult Neural Stem Cells
por: Pons-Espinal, Meritxell, et al.
Publicado: (2017)

DYRK1A promotes dopaminergic neuron survival in the developing brain and in a mouse model of Parkinson's disease
por: Barallobre, M J, et al.
Publicado: (2014)

Green Tea Polyphenols Rescue of Brain Defects Induced by Overexpression of DYRK1A
por: Guedj, Fayçal, et al.
Publicado: (2009)

Attention deficits without cortical neuronal deficits
por: Zénon, Alexandre, et al.
Publicado: (2012)

Immunization of Rats With Cholinergic Neurons Induces Behavioral Deficits
por: Chapman, Joab, et al.
Publicado: (1989)

DYRK1A Overexpression in Mice Downregulates the Gonadotropic Axis and Disturbs Early Stages of Spermatogenesis
por: Dard, Rodolphe, et al.
Publicado: (2021)

Targeting trisomic treatments: optimizing Dyrk1a inhibition to improve Down syndrome deficits
por: Stringer, Megan, et al.
Publicado: (2017)

Autism-associated Dyrk1a truncation mutants impair neuronal dendritic and spine growth and interfere with postnatal cortical development
por: Dang, T, et al.
Publicado: (2018)

Mutational analysis of two residues in the DYRK homology box of the protein kinase DYRK1A
por: Widowati, Esti Wahyu, et al.
Publicado: (2018)

Early Effects of the Soluble Amyloid β(25-35) Peptide in Rat Cortical Neurons: Modulation of Signal Transduction Mediated by Adenosine and Group I Metabotropic Glutamate Receptors
por: Castillo, Carlos Alberto, et al.
Publicado: (2021)

Correction of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A
por: Nguyen, Thu Lan, et al.
Publicado: (2018)

DYRK1A Protein, A Promising Therapeutic Target to Improve Cognitive Deficits in Down Syndrome
por: Feki, Anis, et al.
Publicado: (2018)

DCAF7/WDR68 is required for normal levels of DYRK1A and DYRK1B
por: Yousefelahiyeh, Mina, et al.
Publicado: (2018)

Differential maturation and chaperone dependence of the paralogous protein kinases DYRK1A and DYRK1B
por: Papenfuss, Marco, et al.
Publicado: (2022)

Overexpression of the human MNB/DYRK1A gene induces formation of multinucleate cells through overduplication of the centrosome
por: Funakoshi, Eishi, et al.
Publicado: (2003)

Novel DYRK1A Inhibitor Rescues Learning and Memory Deficits in a Mouse Model of Down Syndrome
por: Stensen, Wenche, et al.
Publicado: (2021)

Emerging roles of DYRK2 in cancer
por: Tandon, Vasudha, et al.
Publicado: (2021)

Overexpression of serotonin receptor 5b expression rescues neuronal and behavioral deficits in a mouse model of Kabuki syndrome
por: Tang, Gang-Bin, et al.
Publicado: (2020)

Architecture of the Synaptotagmin-SNARE Machinery for Neuronal Exocytosis
por: Zhou, Qiangjun, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pe6htle0mp1u0ni4lstd50ntq7